藥物篩選&開(kāi)發(fā)技術(shù)論壇 DSDT 2015將在上海召開(kāi)
Drug Screening and Discovery Technologies Asian Forum 2015
Jan.21 (Wednesday) to Jan.22 (Thursday).2015
InterContinental Shanghai Pudong Hotel
Produced by: Deliver Consulting Limited
Supported by: Society for Laboratory Automation and Screening
Program Overview
The ‘Drug Screening and Discovery Technologies Asian Forum 2015’ is the annual forum produced by Deliver Consulting, exclusively focusing on the Asian concurrent screening and discovery technologies and innovation and is aiming to construct efficient dialogues for the improved scientific communication, partnership and is expecting invite over 35 keynote speakers and 200 senior scientists, Chief/Principal Investigators, R&D executives on target identification and validation; assay development and screening, library strategies and management, hit-to-lead exploration and early safety and efficacy assessment.
Program Key Discussions
► Target-based and Phenotypic Screening and Drug Discovery
► Functional Genomics and High Content Screening
► Natural Products Screening and Chemistry
► Screening Library Strategies, Virtual Screening and Library Management
► Novel Discovery Techniques and Assay Models
Confirmed Keynote Speakers
▪ Prof. Ming-Wei Wang, Director, The National Center for Drug Screening, CAS
▪ Prof. Li-Xin Zhang, Deputy Director, CAS Key Laboratory of Pathogenic Microbiology & Immunology; Inaugural Director for Drug Discovery Center for TB, Institute of Microbiology, CAS
▪ Prof. Baoxue Yang, Chair, Department of Pharmacology, School of Basic Medical Sciences, Peking University
▪ Prof. Wensheng Wei, Principal Investigator, College of Life Sciences, Peking University
▪ Prof. Lili Wang, Pharmacology Professor, Beijing Institute of Pharmacology and Toxicology
▪ Prof. Xulin Chen, Director, Antiviral Research Group, State Key Laboratory of Virology, Wuhan Institute of Virology, CAS
▪ Prof. Qing-Song Liu, Principal Investigator, Vice Director, Life Science Dept. High Magnetic Field Laboratory, CAS
▪ Prof. Jonathan Baell, Professor, MIPS, Monash University
▪ Prof. Hiroyuki Osada, Group Director, Chemical Biology Group, Deputy Director, Riken Center for Sustainable Resource Science
▪ Prof. Thomas Dick, Head, Antibacterial Drug Discovery Laboratory, The National University of Singapore
▪ Dr. Kurt Lackovic, Business and HTS Development Manager, The Walter + Eliza Hall Institute of Medical Research
▪ Prof. Ho-Jeong Kwon, Chairman, Dept. of Biotechnology, Yonsei University
▪ Prof. Seung-Bum Park, Director for Chemical Proteomics, Seoul National University
▪ Prof. Joon-Myong Song, Chair, Department of Pharmacy, Seoul National Unversity
▪ Dr. Kanury Rao, Head, Drug Discovery Research Centre, THSTI, Ministry of Science and Technology, Govt. of India
▪ Dr. Marc Bickle, Head, HT-Technology Development Studio, Max Planck Institute of Molecular Cell Biology and Genetics, Germany
▪ Dr. Zhiyuan Zhang, Director, Translational Research Center, NIBS
▪ Dr. Giridharan Periyasamy, Head, Centre for High Throughput Phenomics, Genome Institute of Singapore
▪ Prof. Meng-Ru Shen, Associate Dean for Research, Chair of Pharmacology, National Cheng Kung University
Please click here to review the up-to-date speaker panel and research focus.
Who Should Attend
Approx. 200 senior scientists, Chief/Principal Investigators, R&D executives are expected to attend 'Drug Screening and Discovery Technologies Asian Forum 2015', attracting a strong contingent throughout Asia Pacific, US and EU. The participants will mainly come from academia, research institutes, pharmaceutical and biotechnology companies and hospitals with the main responsibilities including but not limited to:
|
▪ Target Identification and Validation |
▪ Preclinical Development |
|
▪ Assay Development |
▪ ADME |
|
▪ Laboratory Automation |
▪ Medicinal Chemistry |
|
▪ Compound Profiling |
▪ Chemical Biology |
|
▪ High Content Analysis |
▪ Chemical Genomics |
|
▪ Cell Biology |
▪ Chemical Genetics |
|
▪ Natural Products Research |
▪ Biochemical/Cellular Assay |
|
▪ Stem Cell Research |
▪ Functional Genomics |
|
▪ Lead Generation |
▪ Compound Management |
Joining as a Delegate
Currently conference registration is available. Register before Nov.25. 2014, you will receive the reduced rate at CNY 5,000 / USD 820 for commercial organizations and CNY 3,500 / USD 575 for academia. Corporate will also enjoy considerable discounts by sending team to this conference.
Exhibiting and Supporting Opportunities
Exhibiting and supporting this screening forum is an effective measure to promote and reinforce your latest findings, cutting-edge products and services to a highly targeted group of key decision makers, scientists and end-users who are aiming to improve their assay development, screening and drug discovery productivity. These marketing and industry supporting opportunities also help committee to underwrite the cost of a service, program or incentive that we provide to conference attendees. Therefore, in addition to the branding recognition that you will receive, the committee also provides extra benefits to show our gratitude to those organizations of certain support levels.
Presenting a Poster
All attendees are encouraged to present a poster on the blackboard at site. The specification is A3 297 *420 mm, colorful with high resolution. All posters shall be printed out and carried by the registered organization.
For more information and enquiries about the latest forum agenda and speaking arrangement; attending, exhibiting and supporting options, please contact with:
Wei Zhang
Project Manager
86.21.6034.0229
wzhang@deliver-consulting.com
- 因美納邀您參加CSCO第九屆血液腫瘤學(xué)術(shù)大會(huì)
- 千奧星科精彩亮相2025神經(jīng)科學(xué)技術(shù)研討會(huì)
- 諾達(dá)思攜多款產(chǎn)品亮相2025中國(guó)人類工效學(xué)學(xué)術(shù)會(huì)議
- 美森與您相約CMC-CHINA第七屆中國(guó)制藥工業(yè)博覽會(huì)
- CPHI&PMEC 2025制藥工業(yè)展（深圳）通知
- 2026第三十三屆成都醫(yī)療健康博覽會(huì)邀請(qǐng)函
- NGDx2025中國(guó)先進(jìn)診斷技術(shù)開(kāi)發(fā)與應(yīng)用論壇議程表
- 關(guān)于征集藥食同源及藥膳配方食品標(biāo)準(zhǔn)試點(diǎn)單位的通知
- 關(guān)于征集藥食同源優(yōu)選產(chǎn)品評(píng)價(jià)規(guī)范參編單位的通知
- QD中國(guó)攜單細(xì)胞方案亮相國(guó)際干細(xì)胞研究學(xué)會(huì)年會(huì)
- 維拓啟創(chuàng)助力2025表面肌電論壇在杭成功召開(kāi)
- 易科泰應(yīng)邀參加動(dòng)物遺傳專業(yè)委員會(huì)2025年學(xué)術(shù)年會(huì)
- 奧偉登攜前沿顯微技術(shù)亮相廈門2025中國(guó)材料大會(huì)
- CIIDC 2025中國(guó)（成都）儀器創(chuàng)新發(fā)展大會(huì)通知
- 2025新疆（昌吉）農(nóng)業(yè)展覽會(huì)即將震撼啟幕
- 瑞孚迪亮相第六屆跨國(guó)公司領(lǐng)導(dǎo)人青島峰會(huì)
- 奧盛核酸檢測(cè)分析儀入選國(guó)家重點(diǎn)研發(fā)計(jì)劃產(chǎn)品清單
- 華益美生物攜手尚元醫(yī)療精彩亮相全國(guó)血站管理大會(huì)
- 華益美生物攜手尚元醫(yī)療閃耀2025 CACLP
- 天隆科技AI機(jī)器人驚艷亮相CACLP 2025提供沉浸式逛展
- 天隆聯(lián)合西安交大共同推進(jìn)的國(guó)家醫(yī)學(xué)中心正式啟動(dòng)
- 天隆科技攜創(chuàng)新產(chǎn)品精彩亮相迪拜2025 Medlab展會(huì)
- 尚元醫(yī)療攜核酸提取儀等產(chǎn)品亮相慕尼黑分析生化展
- 集團(tuán)三大公司首次海外聯(lián)合參展，天隆亮相2024MEDICA
- 天隆將參展2024長(zhǎng)三角傳染病監(jiān)測(cè)預(yù)警病原學(xué)檢測(cè)會(huì)
- 天隆科技參與多病原核酸檢測(cè)重大科研項(xiàng)目正式啟動(dòng)
- 天隆參與起草的醫(yī)療機(jī)構(gòu)藥物基因檢測(cè)標(biāo)準(zhǔn)發(fā)布并實(shí)施
- 蘇州尚元醫(yī)療儀器產(chǎn)品免費(fèi)試用暨全國(guó)經(jīng)銷商招募
- 中食藥檢定研究院李靜莉等一行相關(guān)領(lǐng)導(dǎo)蒞臨天隆調(diào)研
- 天隆Panall 8000入選"中關(guān)村論壇"十大首發(fā)高端產(chǎn)品
Copyright(C) 1998-2025 生物器材網(wǎng) 電話：021-64166852;13621656896 E-mail：info@bio-equip.com